About Us
Overview
Management Team
Charles H Large
Giuseppe S. Alvaro
Daniel Umbricht
Barbara Domayne-Hayman
Martin Gunthorpe
Hannah Selin
Alice Sharman
Wendy Kennedy
Board of Directors
Investors
Pipeline
Overview
Fragile X Syndrome
Orphan Epilepsy Syndromes
Science
Partnering
News & Events
Publications
Careers
Contact Us
Menu
Menu
About Us
Investors
Autifony Therapeutics Limited is a privately funded company.
Main investors
Additional funding has been received from:
Scroll to top